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Abstract
 
The structure-specific endonuclease ERCC1-XPF is an essential component of the nucleotide
excision DNA repair pathway. ERCC1-XPF nicks double-stranded DNA immediately adjacent
to 3
 
 
 
single-strand regions. Substrates include DNA bubbles and flaps. Furthermore, ERCC1
interacts with Msh2, a mismatch repair (MMR) protein involved in class switch recombination
(CSR). Therefore, ERCC1-XPF has abilities that might be useful for antibody CSR. We
tested whether ERCC1 is involved in CSR and found that 
 
Ercc1
 

 
/
 
 
 
splenic B cells show mod-
erately reduced CSR in vitro, demonstrating that ERCC1-XPF participates in, but is not
required for, CSR. To investigate the role of ERCC1 in CSR, the nucleotide sequences of
switch (S) regions were determined. The mutation frequency in germline S
 
 
 
segments and
recombined S
 

 
-S
 

 
3 segments cloned from 
 
Ercc1
 

 
/
 
 
 
splenic B cells induced to switch in culture
was identical to that of wild-type (WT) littermates. However, 
 
Ercc1
 

 
/
 
 
 
cells show increased
targeting of the mutations to G:C bp in RGYW/WRCY hotspots and mutations occur at sites
more distant from the S–S junctions compared with WT mice. The results indicate that
ERCC1 is not epistatic with MMR and suggest that ERCC1 might be involved in processing
or repair of DNA lesions in S regions during CSR.
Key words: ERCC1-XPF • antibody • heavy chain • DNA repair • mouse B cells
 
Introduction
 
Activation of B lymphocytes by antigen and costimulatory
signals, usually from T lymphocytes, initiates two processes
of antibody diversification. Somatic hypermutation (SHM)
introduces mutations in the variable region genes, which,
in conjunction with antigen selection, generates antibodies
with increased affinity. The second process, class switch re-
combination (CSR), enables B cells to diversify the constant
region and thereby the effector function of the antibody
molecule, while maintaining the same antigen-binding do-
main. These two mechanisms have several shared features
but both are poorly understood.
CSR occurs by an intrachromosomal deletional recombina-
tion between switch (S) region sequences located upstream
of the constant region genes. S region sequences consist of
tandem repeats of short (20–80 bp) consensus elements, ex-
tending from 2 to 10 kb in length, and recombination can
occur at any site within the S regions. The process is thought
to be initiated by the creation of double-strand breaks
within the S regions (1, 2), consistent with the ability to detect
the deleted DNA as a circle (3). Although the different S
regions have short sequence elements in common (e.g.,
GGGGT, GGGCT, or GAGCT), they differ too much to
undergo homologous recombination and CSR is thought to
occur by a type of nonhomologous end joining (NHEJ; ref-
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erences 4 and 5). This is supported by the occurrence of
very few bp of microhomology at the S–S junctions, which
is typical of NHEJ (6), and by the demonstration that the
NHEJ proteins Ku70 and Ku80 are required for CSR (7–9).
Although DNA-PKcs is required for switching to all iso-
types except IgG1 (10), interestingly, its kinase activity is
not (11).
Activation-induced cytidine deaminase (AID) is essential
for both SHM and CSR (12, 13), and the data indicate its
role is to convert dC to dU residues within variable genes
and S regions (14–16). Resolution of the dU residues could
introduce mutations that are characteristic both of SHM
and of segments surrounding S–S junctions (17, 18). Fur-
thermore, removal of the dU residues by the base excision
repair (BER) pathway could introduce the DNA breaks
necessary to initiate CSR. This has not been demonstrated;
however, CSR is 90% reduced in B cells from mice defi-
cient in the BER enzyme uracil DNA glycosylase (UNG)
that excises dU residues (19), and even more severely re-
duced in some patients with hyper IgM syndrome caused
by deleterious mutations in UNG (20).
Mismatch repair (MMR) proteins are also involved in both
CSR and SHM, although their roles are not yet clear. B cells
from mice deficient in Msh2, Msh6, Mlh1, or Pms2 and
combinations thereof have reduced abilities (two- to seven-
fold) to undergo CSR and have altered S–S recombination
junctions (21–27). Additionally, mutations in segments sur-
rounding the CSR junctions are increased in MMR-deficient
mice (25, 28), consistent with the known role for Msh2,
Msh6, Mlh1, and Pms2 in identification of DNA mismatches
and recruitment of repair factors during MMR.
Msh2 and Msh3 participate in homologous recombina-
tion in 
 
Saccharomyces cerevisiae
 
 (29, 30), removing nonho-
mologous DNA ends in double-strand break repair (31).
 
Rad1
 
 and 
 
rad10
 
 mutants have phenotypes similar to 
 
msh2
 
and 
 
msh3
 
 mutants with regard to homologous recombina-
tion (32, 33) and DNA end processing (31, 34, 35). Rad1
and Rad10 form a complex with endonuclease activity
(36), and Rad10 and Msh2 interact in two-hybrid and
coimmunoprecipitation assays (37, 38). Thus, it has been
proposed that Msh2-Msh3 recognize recombination and
repair intermediates, and then recruit the endonuclease
Rad10-Rad1 for incision (34). Consistent with its role in
yeast, the available evidence suggests that one of the roles
of Msh2 in CSR is to perform end processing (21, 24, 39).
However, current evidence indicates that Msh3 has little or
no role in CSR (26, 27).
ERCC1-XPF, the mammalian homologue of Rad10-
Rad1, is a structure-specific endonuclease that nicks double-
stranded DNA immediately adjacent to a 3
 
 
 
single-stranded
tail (40). This activity allows it to remove nonhomologous 3
 

 
DNA ends, facilitating homologous recombination (41–44).
In addition, ERCC1-XPF is an essential component of the
nucleotide excision repair (NER) pathway. This pathway re-
moves helix-distorting DNA lesions by incising the damaged
strand on either side of the lesion to remove the damaged
patch followed by resynthesis to fill the gap (45).
S regions must be transcribed to undergo CSR, and the
transcript has been shown to form an RNA–DNA hybrid
(R loop) with S region sequences (46, 47). This structure
results in the formation of single-stranded DNA, which can
be a target for AID (15, 48–51). ERCC1-XPF has been
shown in vitro to cleave R loop structures at the site of the
double-strand DNA–R loop transition (52). However, the
absolute requirement for AID in CSR makes it highly un-
likely that ERCC1-XPF is required to initiate CSR by rec-
ognition of R loops before cytidine deamination by AID.
To investigate a potential role for ERCC1-XPF, we an-
alyzed CSR in splenic B cells isolated from mice deficient
in ERCC1. Our data show that ERCC1-XPF is not essen-
tial for CSR, as has been recently reported by others (53,
54). However, we find that switching efficiency is reduced
in ERCC1-deficient B cells and that the location and spec-
ificity of mutations introduced into S regions during CSR
are altered, indicating that ERCC1-XPF participates in the
DNA repair required for CSR.
 
Materials and Methods
 
Mice. Ercc1
 

 
/
 
 
 
mice and littermate controls were generated
by heterozygote crosses in a mixed C57Bl/6:FVBn genetic back-
ground. Animals were killed by CO
 
2 
 
asphyxiation 19–21 d post-
partum and their spleens were removed. Genotyping was per-
formed by PCR as described previously (55). Mice were typed
for the 
 
pol 
 
 
 
gene as described previously (56) and the 
 
Ercc1
 

 
/
 

 
mice and their WT littermates were 
 
pol 
 

 

 
/
 

 
.
 
B Cell Isolation and Cultures.
 
Splenic B cells were isolated by
T cell depletion with antibody and complement, and cultured as
described previously (24). To induce switch recombination to
IgG3, 50 
 

 
g/ml LPS (Sigma-Aldrich) and 0.3 ng/ml anti–
 
 
 
dex-
tran (provided by C. Snapper, Uniformed Services University of
the Health Sciences, Bethesda, MD) were added at the initiation
of culture. To induce switch recombination to IgG1, LPS and
IL-4 (800 U/ml; provided by W. Paul, National Institutes of
Health, Bethesda, MD) were added. LPS and IFN-
 
 
 
(10 U/ml)
were used to induce IgG2a switching, and LPS and dextran sul-
fate (30 
 

 
g/ml; Amersham Biosciences) were used to induce
IgG2b switching. LPS, 2 ng/ml TGF-
 

 
1, IL-4, 150 U/ml IL-5
(BD Biosciences), and anti–
 
 
 
dextran were used to induce IgA
CSR. To induce IgE CSR, cells were cultured at a lower density
(12.5 
 
	 
 
10
 
4
 
/ml) and treated with LPS and IL-4 (50,000 units/ml)
for 5 d (57). Some cultures also included 100 ng/ml BLyS (Hu-
man Genome Sciences). BLyS did not alter the relative amount
of CSR obtained in WT and 
 
Ercc1
 

 
/
 
 
 
B cell cultures. To detect
IgE expressed on B cell surfaces, it is necessary to remove any IgE
bound to CD23 (low affinity IgE receptor) due to IgE secretion
into the cultures by the few cells that have switched to IgE ex-
pression. We tested both anti-CD23 blocking antibody (57) or
treatment of fixed cells with acid (50 mM NaOAc, 85 mM NaCl,
5 mM KCl, 1% FCS, pH 4.0) and found that acid treatment
alone worked as well as both procedures combined (see Fig S1,
available at http://www.jem.org/cgi/content/full/jem.20040052/
DC1, and unpublished data). Without this treatment, we found
artifactual staining with anti-IgE antibody, in which 70–90% of
the cells were stained.
For carboxyfluorescein diacetate succinimidyl ester (CFSE) la-
beling, cells were washed in serum-free HBSS (GIBCO BRL)
and resuspended at 40 
 
	 
 
10
 
6
 
/ml. An equal volume of 2.4 
 

 
M
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CFSE was added and cells were incubated at 37
 


 
C for 12 min,
and then washed with medium containing 10% FCS. Cells were
then diluted and cultured as described above.
 
PCR Amplification and Cloning of S
 

 
–S
 

 
3 Junctions and Germline
(GL) S
 
 
 
and S
 

 
3 Segments.
 
Genomic DNA was isolated from
purified splenic B cells ex vivo or after culture as indicated (24).
S
 

 
–S
 

 
3 junctions E8–E86 were amplified from genomic DNA
by PCR using the Expand Long Template Taq and Pfu polymer-
ase mix (Roche) and the primers 
 

 
3-H3 and g3-2 (24). S
 

 
–S
 

 
3
junctions E188–E245 were amplified using primers Smu1 and
Sg3-4 (25). These primers hybridize 168 bp 5
 
 
 
to and 40 bp 3
 
 
 
to
the first primer set. Different primers were used for GL 5
 
 
 
S
 
 
 
se-
quences, 5
 

 
3 and 3
 

 
2 (28, 58). Sequences located at the 5
 
 
 
end
of this segment were analyzed. The primers used to amplify the
GL S
 

 
3 fragment were 
 

 
3-1 and g3-2 (28).
PCR products were cloned into the vector pCR4-TOPO
(Invitrogen). For measurement of the mutation frequency and
spectrum within recombined S
 

 
–S
 

 
3 segments, only clones
whose S
 
 
 
or S
 

 
3 segments were completely sequenced were in-
cluded. The PCR error frequency in our experiments was previ-
ously determined by sequencing several independent amplifica-
tions of the single S
 

 
–S
 

 
3 junction from the plasmacytoma
TIB114, using procedures identical to ones used for splenic B
cell junctions (28).
 
Online Supplemental Material.
 
The following supplemental
figures are available at http://www.jem.org/cgi/content/full/
jem.20040052/DC1: Fig. S1, surface IgE expression (FACS
 
®
 
data); Fig. S2, surface IgG or IgA expression in total 
 
Ercc
 
1
 

 
/
 
 
 
B
cell populations relative to WT cells; Fig. S3, nucleotide muta-
tions in GL S
 
 
 
segments; Fig. S4, sequences of S
 

 
–S
 

 
3 junctions
Figure 1. Reduced switching in Ercc1/ splenic B cells is not due to a reduction in cell proliferation. (A) The percent of Ercc1/ B cells in S phase, as
determined by flow cytometry of propidium iodide–stained cells, after stimulation with LPS plus anti– dextran for 2 d is slightly reduced. One heterozy-
gous and two WT littermates are shown for comparison. (B) CFSE-stained B cells cultured for 4 d with the indicated inducers lose CFSE staining by 50%
with each cell division. The dark line represents the fluorescence tracing and the peaks within the fluorescence tracing are integrations representing indi-
vidual cell generations that are enumerated above the graph. (C) Cells from the indicated generations were gated on and analyzed for IgG1 expression
(other isotypes not shown). (D) Surface IgG or IgA expression by Ercc1/ cells is shown as a percent of expression of WT cells ( SEM) after 4 d in cul-
ture with appropriate CSR inducers. Only cells that divided six or more times were analyzed and the percent switching to each isotype relative to WT is
shown ( SEM). n  3 for all isotypes, except for IgA, where n  1. The differences between WT and Ercc1/ switching for all isotypes are highly
significant: P  0.001 as determined by a paired t test.
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from 
 
Ercc1
 

 
/
 
 
 
cells; Fig. S5, sequences of recombined S
 
 
 
seg-
ments (using 
 

 
3-H3 and g3-2 primers) from 
 
Ercc
 
1
 

 
/
 
 
 
cells; Fig.
S6, sequences of recombined S
 

 
3 segments (using 
 

 
3-H3 and
g3-2 primers) from 
 
Ercc
 
1
 

 
/
 
 
 
cells; Fig. S7, sequences of recom-
bined S
 
 
 
segments (using Smu1 and Sg3-4 primers) from 
 
Ercc
 
1
 

 
/
cells; and Fig. S8, sequences of recombined S3 segments (using
Smu1 and Sg3-4 primers) from Ercc1/ cells.
Results
ERCC1-deficient mice have a severe growth defect and
die 3 wk after birth due to liver failure (59–61). Spleens
harvested from 19–21-d-old Ercc1/ mice had 10-fold
fewer cells than their WT littermates, disproportionate
compared with their total body weight (40% of WT). To
determine whether these mice have mature B cell popula-
tions, we stained spleen cells with anti-B220, anti-CD23,
and anti-CD21, and analyzed them by flow cytometry.
Despite their reduced cellularity, Ercc1/ spleens contain
populations of marginal zone follicular and immature B
cells that are proportional to those of their WT littermates
(unpublished data).
Next, we examined splenic B cells from Ercc1/ mice in
an in vitro isotype switching assay to determine if class
switching is affected by ERCC1 deficiency. Spleens were
harvested from KO and WT littermates at 19–21 d postna-
tum, and B cells were cultured for 4 d with LPS and cyto-
kines to induce CSR to IgG3, IgG1, IgG2b, IgG2a, and
IgA as described previously (23). We found a moderate re-
duction (20–55%) in class switching to all of these isotypes
in the Ercc1/ cells, which was highly reproducible and
significant (P  0.001; Fig. S2, available at http://
www.jem.org/cgi/content/full/jem.20040052/DC1). We
also attempted to measure IgE CSR in cells cultured for
5 d, but were unable to detect significant levels of IgE sur-
face–expressing cells in WT or Ercc1/ cultures (Fig. S1;
refer to Materials and Methods).
Although mature B cell populations appeared to be nor-
mal, the serious growth defects in Ercc1/ mice led us to
ask whether a decrease in the rate of cell division may un-
derlie the decrease in class switching. Indeed, in both
[3H]thymidine uptake (not depicted) and propidium iodide
cell cycle analysis (Fig. 1 A), mutant B cells did lag slightly
behind WT B cells in the rate of cell division (76% of con-
trol cells). To control for the rate of cell division, we
stained cells with the vital dye CFSE to follow cell division
in culture. After 4 d, we further stained the cells with PE-
coupled anti-Ig isotype antibodies to assay class switching.
By day 4, most of the viable cells in both Ercc1/ and WT
cultures had divided five or more times, with Ercc1/ cells
lagging slightly behind WT cells (Fig. 1 B). We then ana-
lyzed class switching in cells that had divided six to nine
times. Although the frequency of switched cells increased
with cell division number in both Ercc1/ and WT cells
(Fig. 1 C and not depicted), switching was still reduced in
Table I. In Vitro Ercc1 Class Switching in Successive Cell 
Generations as a Percent of WT Switching
Cell generation IgG1 IgG2a IgG3
6 83.2 82.5 52.3
7 79.1 70.4 61.4
8 75.6 74.6 56.4
9 72.3 77.7 53.2
Table II. The Mutation Frequency in Switch Region Segments from Ercc1 Splenic B Cells Induced to Undergo CSR in Culture with LPS 
Plus Anti– Dextran Does Not Differ from WT Littermates
Row Mutation frequency (	104) Total nucleotides of sequenced Number of mutations p-valueb
WT B cellsa
1 GL 5 S 15.1 33,743 51 0.041
2 Recombined S 35.0 8,003 28 0.001
3 Recombined S3 30.3 12,890 39 0.001
Ercc1 B cells
4 GL 5 S 17.9 24,536 44 0.012
5 Recombined S 41.2 8,254 34 0.001
6 GL S3 (5  3)c 8.4 18,537 18 0.560
7 Recombined S3 31.5 9,534 30 0.001
8 PCR error frequencyd 7.4 12,182 9
aWT () 3-wk-old ercc1 littermates.
bSignificance of difference from PCR error frequency (Fisher’s exact t test).
cGL S3 segments cloned from mature WT mice from a different background (pms2 and msh2) had a mutation frequency of 8.0 	 104 mutations
per bp (reference 28).
dDetermined from eight independent PCR amplifications of a recombined S–S3 segment from the S segment, the TIB114 myeloma cell line
(reference 28).
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all Ercc1/ cell populations relative to WT cells (Fig. 1 C
and Table I). We analyzed expression of switched isotypes
in cells that had divided six or more times in three inde-
pendent experiments and found that class switching was re-
duced in the Ercc1/ B cells relative to WT cells (P 
0.001 for all isotypes shown; Fig. 1 D). From this we con-
clude that the moderate but consistent reduction in class
switching in Ercc1/ B cells is not due to reduced cell divi-
sion, and that ERCC1 may therefore have a role in CSR.
Altered Mutation Spectrum in the Unrecombined S Alleles
from Ercc1 B Cells. Unrecombined or GL S alleles in
B cells that have been activated to undergo CSR accumu-
late nucleotide substitutions, presumably due to aborted
switch events (9, 28, 58, 62). To begin to determine
whether ERCC1 might be involved directly in CSR, we
examined the mutation frequency and spectrum in the GL
5 S segments from activated Ercc1/ B cells compared
with their 3-wk-old WT littermates (Fig. S3 shows the
mutations identified in both genotypes). Although the mu-
tation frequency was not significantly different between
these two genotypes (Table II, rows 1 and 4), the mutation
spectra differed (Table III). Especially striking is the finding
that mutations in GL S segments from Ercc1/ cells fo-
cused to the two central G:C bp within RGYW/WRCY
hotspots (P  0.001), whereas GL S mutations in WT lit-
termates were not significantly targeted to hotspots. These
data suggest that ERCC1-XPF participates in the error-
prone mechanisms that repair DNA lesions initiated in the
S segment by AID, reducing the fraction of mutations at
AID hotspots. However, because the frequency of muta-
tion is not increased in the absence of ERCC1, other repair
mechanisms appear to compensate for this function of
ERCC1-XPF. The increased targeting of GL S mutations
to G:C bp in hotspots differs from our previous findings in
msh2/ cells.
Switch Recombination Junctions Are Not Altered in Ercc1
Cells. Because ERCC1-XPF is required for end process-
ing during double-strand break repair in yeast and possibly
in mammals (34, 41, 63), we asked whether S–S3 re-
combination junctions are altered in Ercc1/ B cells. We
PCR amplified, cloned, and sequenced 38 S–S3 junc-
tions from Ercc1/ B cells stimulated with LPS plus anti–
dextran for 4 d. Similarly, 46 S–S3 junctions were am-
plified from 3-wk-old WT (Ercc1/) littermates. No dif-
ference in the lengths of junctional microhomology or fre-
quency of insertions at S–S3 junctions was observed
between mutant and WT littermates (Table IV). As we
have previously found that Msh2 deficiency results in de-
creased junctional microhomology and increased insertions
at junctions, these data provide a further distinction be-
Table III. Sequence Specificity of Mutations in S and S3 Segments from Activateda Ercc1 and WT Splenic B Cells Differ
Recombined Sb p-valued Recombined S3b p-valued GL 5 Sc p-valued
Percent of mutations at G:C nucleotides:
WT littermate 78.5% (28 mutations) 0.048 51% (39 mutations) 0.244 39% (56 mutations) 0.407
Ercc1e 71% (34 mutations) 0.212 68% (31 mutations) 0.575 51% (45 mutations) 0.352
DNA sequence: 59% G/C 61% G/C 43% G/C
Percent of mutations at G:C within RGYW/WRCY Hotspotse:
WT littermate 68% (28 mutations) 0.001 23% (39 mutations) 0.683 22% (51 mutations) 0.095
Ercc1 68% (34 mutations) 0.001 45% (31 mutations) 0.002 40% (45 mutations) 0.001
DNA sequence: 25% G:C bp in hotspots 20% G:C bp in hotspots 13.2% G:C bp in hotspots
aActivated for 4 d with LPS or with LPS plus anti– dextran.
bSegments amplified using the 3H3 and g3-2 or the Smu1 and Sg3-4 primers.
cSegments amplified using the 53 and 32 primers.
dDifference from random DNA sequence base composition by Fisher’s exact test.
eOnly includes mutations at central two G:C bp in RGYW/WRCY sequence.
Table IV. S–S3 Junctions in Ercc1 B Cells Are Similar to Junctions from WT Littermates
Percent of junctions with indicated length of microhomology
Mouse 0–1 bp 2 bp 5 bp 8 bp 10 bp Number of sequences Percent with inserts
WT littermates 70 30 11 9 4 46 17
Ercc1 63 37 13 8 8 38 16
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tween the roles of ERCC1-XPF and Msh2. However,
there was an increase in length of microhomology patches
and insertions in junctions cloned from both the WT and
Ercc1/ cells in these experiments compared with previ-
ously analyzed junctions from 3-mo-old WT mice (24).
This difference might be due to age-related changes or dif-
ferences in genetic backgrounds, but demonstrates the im-
portance of determining the sequences of S junctions from
WT littermates in each experiment.
Mutations Extended Further from the S–S3 Junctions in
Ercc1 Cells and Increased Targeting to G:C bp in Hotspots on
the S3 Side. Mutations are also frequently observed in
the nucleotides surrounding switch recombination junc-
tions, extending 200 bp on either side of the junction (6,
28, 64, 65). Because the S segments are not within exons,
the mutations do not affect antibody function and are
readily tolerated, but they do have implications as to the
mechanism of CSR. To determine whether ERCC1 might
be involved in repair of S–S recombination junctions, we
examined the mutations surrounding S–S3 junctions
from Ercc1/ and WT littermates. The sequences from
Ercc1/ cells are shown in Figs. S5–S8. There was no
change in mutation frequency in DNA segments surround-
ing these junctions in Ercc1/ compared with WT litter-
mate cells (Table II, rows 2 and 3. vs. 5 and 7). However,
the positions of the mutations relative to the S–S3 junc-
tions were significantly different (P  0.001; Fig. 2). WT
cells have the highest density of mutations within 50 bp of
the switch junction (Fig. 2 A), whereas mutations were
spread much more distally in Ercc1/ cells (Fig. 2 B). In
fact, on the S side, the mutation frequency did not de-
crease with increasing distance from the junction in Ercc1/
cells. Because most of the recombined S segments se-
quenced were 300 bp or less, we could not determine if the
mutations extended even further from the junction. This
pattern of mutations is strikingly different from the pattern
observed in Msh2-deficient cells (P  0.001), in which we
found that mutations were even more focused to the S–S
junctions than in the WT cells (28). Although the muta-
tions did not extend further from the junction on the S3
side in Ercc1/ cells as they do on the S side, there were
significantly fewer mutations within 50 bp of the junction
compared with WT cells.
Similar to the Ercc1/ GL S segments, mutations in
the recombined S3 segments in Ercc1/ cells also prefer-
entially occurred at G:C bp in hotspots (P  0.002), unlike
mutations in WT S3 segments (Table III). Mutations in
recombined S segments in WT cells strongly favor G:C
bp in hotspots (P  0.001), and there was no further in-
crease in targeting of the mutations to G:C bp hotspots in
Ercc1/ B cells (Table III). These data suggest that similar
to the GL S segment, the mutation spectrum of switched
segments is altered in the absence of ERCC1, suggesting a
role for ERCC1-XPF in processing CSR intermediates.
Discussion
ERCC1-XPF Participates in, but Is Not Essential for,
CSR. Data presented in this work demonstrate that B
cells deficient in ERCC1 have a mildly reduced ability to
undergo CSR that is not due to reduced cell proliferation.
Sequence analysis of the S region segments in cells induced
to switch with LPS plus anti– dextran demonstrated a
clear difference from WT littermates in the targeting of
mutations found within GL S segments and recombined
S3 segments. Furthermore, the mutations in recombined
Figure 2. Mutations are more clustered at the S–S3 junctions in (A)
WT B cells than in (B) Ercc1/ B cells. The mutation density per 50-bp
segment is plotted. Only segments in which the entire sequence was avail-
able are included. The significance of the differences in mutation distribution
on both the S and S3 sides, and also in toto, are all P  0.001; two-tailed
Mann-Whitney test.
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S segments from Ercc1/ B cells did not cluster near the
S–S junctions, unlike those in WT cells and in msh2/
cells (28). These data demonstrate that ERCC1-XPF par-
ticipates in, but is not required for, CSR. Specifically, the
endonuclease appears to function during the repair of S
segments that initiate CSR but fail to recombine, and also
during successful CSR.
Our data appear to conflict with previous conclusions
that ERCC1-XPF is not involved in CSR. Winter et al.
(53) reported that splenic B cells from Ercc1/ mice switch
in culture to IgG1 and IgE as efficiently as WT cells. Al-
though the Ercc1/ mouse line used in their study was in-
dependently derived from ours (59), these mice are exact
phenocopies. To explain this discrepancy, we note that
IgG1 is the isotype least affected in our assays, and that
IgG1 switching is less sensitive than other Ig isotypes to
various DNA repair deficiencies, including DNA-PKcs
(10, 11) and MMR (21, 23). In addition, Winter et al. (53)
measured IgE CSR by assaying surface-bound IgE, which
can be inaccurate due to the presence of low affinity IgE
receptors (CD23) on B cells (57, 66, 67). In fact, when we
did not acid wash the B cells before staining with anti-IgE
antibody, we found that up to 80% of the B cells in the
cultures bound anti-IgE antibody (Fig. S1). More recently,
it was found that B cells deficient in XPF, the catalytic sub-
unit of the ERCC1-XPF endonuclease (68), also appeared
to switch normally in culture (54). In this work the levels
of IgG1, IgG2b, and IgG3 secreted by activated B cells
from WT and xpf B cells were found to be similar.
However, neither of the above mentioned studies com-
pared the specificity of mutations in the S regions from ac-
tivated mutant and WT B cells. The fact that ERCC1 defi-
ciency has such a modest effect on the level of CSR might
be due to redundancy amongst DNA repair systems.
ERCC1 Is Not Epistatic with Msh2 in CSR. Our find-
ings do not support the model that ERCC1-XPF is re-
cruited by Msh2 to perform end processing during CSR
(21, 23). S–S3 junctions from Msh2-deficient cells show
a reduction in the length of microhomology between the
S and S3 sequences compared with junctions from WT
cells (24). In addition, there is an increased occurrence of
inserted nucleotides at these junctions. B cells lacking the
S tandem repeats are absolutely dependent upon Msh2 to
undergo CSR (39), whereas mice lacking S repeats, but
with WT Msh2, show only two- to fivefold reduced
switching (69). These findings suggest that Msh2 is in-
volved in processing DNA ends during recombination (21,
23, 24, 39). Although Msh2 may indeed be involved in
processing DNA ends, it does not appear to do so by re-
cruiting the endonuclease ERCC1-XPF, unlike the yeast
system in which the homologues Rad1–Rad10 are epistatic
with msh2 and msh3 mutants (35). S–S3 junctions in
Ercc1/ cells differ strikingly from msh2/ junctions, as
does the pattern of mutations surrounding the junctions.
Our results demonstrate that ERCC1-XPF does not func-
tion with Msh2 in CSR. However, ERCC1-XPF may still
be involved in 3 end processing in CSR, as it could be re-
cruited to junctions by other proteins.
ERCC1-XPF Deficiency Affects the Specificity of Mutations
in GL S and in Recombined S3 Segments. Mutations in
the GL S segments in LPS  anti– dextran-activated
WT splenic B cells do not commonly occur at G:C bp
within the known AID target (RGYW/WRCY) sequences
(Table III). AID is required for introduction of mutations
into GL S segments in activated B cells, and it is hypothe-
sized that these mutations are caused by error-prone repair
of AID-initiated lesions that do not result in CSR (58, 62).
Abasic sites, which would be produced by AID and subse-
quent UNG activity, are normally targets for the BER en-
zyme AP endonuclease, which incises the DNA backbone
(70, 71). Although repair is error free when DNA polymer-
ase  inserts the correct nucleotide at this break (72–74), it
is likely that in B cells error-prone polymerases (e.g., pol ,
, and ) are recruited to the break, resulting in insertion of
any nucleotide at the dC bp targeted by AID, and also in-
troduction of mutations in flanking sequences (18, 56, 75–
78). The increased incidence of mutations at G:C bp within
AID target sequences and decreased incidence at other
sites in Ercc1 B cells indicates a role for ERCC1-XPF in
AID-initiated mutagenesis.
NER can also recognize and repair abasic sites in vitro
(79) and might compete with BER to repair AID-initiated
lesions. Additionally, NER is specialized for correcting mu-
tations that distort the DNA helix, e.g., G:A mispairs (44,
79), which might be generated from AID-initiated lesions.
Although NER is also typically error free, this repair ma-
chinery excises a patch of 24 to 32 nucleotides surrounding
a lesion site (44, 80), and if abasic residues created by AID
and UNG were clustered, this could instigate error-prone
repair in the 30 bp flanking the lesion(s). NER cannot oc-
cur in the absence of ERCC1-XPF, which could explain
the focusing of mutations at G:C bp in Ercc1/ B cells.
ERCC1-XPF Suppresses Mutations at Sites Distal to the
S–S3 Junctions. The observation that in Ercc1/ B
cells mutations are spread more distally from S–S junctions
suggests that in WT cells, ERCC1-XPF is required for the
prevention and/or repair of the more distal mutations. The
observation that the mutations extend further from the
junction on the S side than on the S3 side might be due
to a greater rate of transcription on the S side before CSR
(unpublished data). To account for the role of ERCC1-
XPF in suppressing distal mutations, it is possible that a
large S segment (hundreds of nucleotides in length) may
undergo end processing during CSR and if 3 flaps are not
removed in the absence of ERCC1, mutations would be
observed over the entire region.
Conclusions. Our data, taken together with previous re-
ports, suggest that components of three DNA repair sys-
tems, BER, MMR, and NER, are involved in repairing
the lesions initiated by AID during the process of CSR. Al-
though it is unclear how ERCC1-XPF contributes to
CSR, it is possible that it is involved in repairing lesions in-
stigated by AID and that it also contributes to creation of
DNA ends suitable for CSR.
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